Hansoh Pharmaceutical Group Company Limited (HKG:3692)
29.62
-0.70 (-2.31%)
Jun 30, 2026, 4:08 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 179.58 billion as of July 1, 2026. Its market cap has increased by 11.04% in one year.
Market Cap
179.58B
Enterprise Value
144.57B
Revenue
16.72B
Ranking
n/a
PE Ratio
28.65
Stock Price
29.62
Market Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 179.58B, an increase of 61.40%. That is a compound annual growth rate of 7.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 179.58B | -17.78% |
| Dec 31, 2025 | 218.43B | 113.01% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 26.64B |
| Simcere Pharmaceutical Group | 25.30B |
| China Medical System Holdings | 24.88B |
| Sunshine Lake Pharma | 23.04B |
| The United Laboratories International Holdings | 16.63B |
| Grand Pharmaceutical Group | 16.46B |
| Fujian Haixi Pharmaceuticals | 14.17B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |